Jones Day advised Turnstone Biologics Corp. on the deal. Turnstone Biologics Corp. announced the development of patent portfolios covering its oncolytic virus programs, including its current clinical...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here